PARIS -- Repeat revascularizations almost derailed a contemporary cath lab strategy of using SYNTAX II scores for patients with 3-vessel disease, a study suggests. The novel workflow involved using ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. EuroPCR 2014 featured a wide variety of important ...

On Thursday during a Hotline / Late-Breaking Trials session, Dr. Toru Tanigaki of Gifu Heart Center in Gifu, Japan, will present the one-year results of the PROVISION 1 Study, the first-ever Japanese ...

SAN DIEGO, CHRON Volcano Corporation today announced its participation in the Paris course for Revascularization (EuroPCR) from May 17 — 20. Volcano's focus will be on highlighting the strength of its ...

PARIS -- Antiplatelet de-escalation worked well following drug-coated balloon (DCB) placement for acute coronary syndrome (ACS), according to the first randomized trial on this subject. In ...

1. The "Radial Paradox": Higher Femoral Access Site Complications Offsets Radial Benefits Growing acceptance of radial access during cardiac catheterisation to reduce access site complications may ...

Over 11,000 participants from around the globe are once again expected at EuroPCR – a Course tailored for interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, ...

PARIS, FRANCE – No one could accuse EuroPCR 2014 of giving up on renal denervation following the negative results of the only large, randomized, sham-controlled trial of this cutting-edge technology.

Paris, France and Munich, Germany, 22 May, 2025 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is presenting data in a ...

NEW YORK, NY – The Cardiovascular Research Foundation (CRF) will hold a special session providing updates on several key cardiovascular trials on Tuesday, May 20 at this year’s EuroPCR meeting. The ...

Please provide your email address to receive an email when new articles are posted on . Martin W. Bergmann, MD, presented 3-month outcome data of patients with atrial fibrillation treated with a ...

At the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference in Washington, DC, investigators from Gifu Heart Center and Fukuoka Sanno Hospital ...